Literature summary extracted from

Nithipatikom, K.; Endsley, M.P.; Moore, J.M.; Isbell, M.A.; Falck, J.R.; Campbell, W.B.; Gross, G.J.
Effects of selective inhibition of cytochrome P-450 w-hydroxylases and ischemic preconditioning in myocardial protection (2006), Am. J. Physiol., 290, H500-H505.

Inhibitors

EC Number	Inhibitors	Comment	Organism	Structure
1.14.15.3	N-methylsulfonyl-12,12-dibromododec-11-enamide	0.4 mg/kg, significant inhibition	Canis lupus familiaris

Organism

EC Number	Organism	UniProt	Comment	Textmining
1.14.15.3	Canis lupus familiaris	-	dog	-

Source Tissue

EC Number	Source Tissue	Comment	Organism	Textmining
1.14.15.3	heart	-	Canis lupus familiaris	-
1.14.15.3	myocardium	-	Canis lupus familiaris	-

Substrates and Products (Substrate)

EC Number	Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
1.14.15.3	arachidonic acid + NADPH + H+ + O2	-	Canis lupus familiaris	20-hydroxyeicosatetraenoic acid + NADP+ + H2O	-	?

Synonyms

EC Number	Synonyms	Comment	Organism
1.14.15.3	CYP omega-hydroxylase	-	Canis lupus familiaris
1.14.15.3	cytochrome P-450 omega-hydroxylase	-	Canis lupus familiaris

Cofactor

EC Number	Cofactor	Comment	Organism	Structure
1.14.15.3	NADPH	-	Canis lupus familiaris

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)